Interestingly, TET2, an enzyme that catalyzes DNA demethylation, is a tumor suppressor in prostate cancer and is frequently mutated, with loss of TET2 expression associated with cancer progression and reduced patient survival (69, 88). The gene discussed is TET2; the disease is Familial prostate cancer.